tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

InhaleRx Director Sean Williams Increases Stake via Entitlement Offer

Story Highlights
  • Director Sean Williams increased his indirect shareholding in InhaleRx through structures including a family trust and super fund.
  • Participation in InhaleRx’s entitlement offer added new shares and free options to Williams’ holdings, signaling board support for the capital raise.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
InhaleRx Director Sean Williams Increases Stake via Entitlement Offer

Claim 70% Off TipRanks This Holiday Season

An announcement from InhaleRx Limited ( (AU:IRX) ) is now available.

InhaleRx Limited has disclosed a change in the indirect holdings of director Sean Williams following his participation in the company’s recent entitlement offer. Williams holds his interests through TG Advisory Pty Ltd as trustee for the Williams Glenair Family Account and the S & C Williams Super Account, reflecting a mix of fully paid ordinary shares, unlisted options and performance rights.

The disclosure shows Williams acquired 42,777 new shares at an issue price of $0.025 under the entitlement offer, increasing his total shareholding to 983,920 shares, and received 21,389 free attaching options expiring in December 2027, with all existing option and performance right holdings unchanged. The move modestly lifts director equity exposure and underscores board support for the capital-raising initiative, which may be viewed positively by investors monitoring alignment between management and shareholder interests.

More about InhaleRx Limited

Average Trading Volume: 287,952

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$5.39M

For detailed information about IRX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1